The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Strattera-40-MG-Oral-Capsule
Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting. It is thought to work by restoring the balance of certain natural substances (neurotransmitters) in the brain.
Stomach upset, nausea, vomiting, constipation, tiredness, loss of appetite/weight loss, dry mouth, dizziness, drowsiness, trouble sleeping, or decrease in sexual ability/desire may occur. In women, menstrual cramps or missed/irregular periods may also occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. To lessen the chance of dizziness, get up slowly from a sitting or lying position. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. This medication may raise your blood pressure. Check your blood pressure regularly and tell your doctor if the results are high. Tell your doctor right away if you have any serious side effects, including: difficulty urinating, unusually fast/irregular heartbeat, fainting, numbness/tingling. Atomoxetine may rarely cause serious (possibly fatal) liver disease. Get medical help right away if you have any symptoms of liver damage, including: dark urine, persistent nausea/vomiting/loss of appetite, stomach/abdominal pain, yellowing eyes/skin. This medication may rarely cause serious problems such as a heart attack or stroke. Get medical help right away if you experience any of the following: chest/jaw/left arm pain, shortness of breath, unusual sweating, weakness on one side of the body, confusion, slurred speech, sudden vision changes. Rarely, males (including young boys and teens) may have a painful or prolonged erection lasting 4 or more hours while using this medication. Caregivers/parents should also be watchful for this serious side effect in boys. If a painful or prolonged erection occurs, stop using this drug and get medical help right away, or permanent problems could occur. Ask your doctor or pharmacist for more details. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
SAVEDefeatured manifold drugStrattera (atomoxetine) is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help the body make more decisions about whether or not to eat/drink/choose/drink.
CapsuleDo not take Strattera if you have ever had an allergic reaction to it, a muscle relaxer, a sleeping pill, or any other similar drug. Tell your doctor if you are taking any other types of drugs including non-prescription or over the counter medicines, vitamins, minerals, or herbal products. Some people may experience drowsiness or dizziness when taking Strattera. Alcohol, marijuana, or cocaine can make some people drowsier.
Strattera (Atomoxetine) can be purchased by calling +1-888-704-0408 and talking with a customer service representative, or by placing an online order at liferxpharmacy.com. Customer Support is also aided by using the chat feature. For additional information, visit the "How to Order" page on liferxpharmacy.com.
Strattera (Atomoxetine) is a medication that can only be purchased with a doctors prescription. While processing your order for the medication, it is necessary to get a valid prescription from your doctor The prescription can be scanned, emailed, or uploaded at liferxpharmacy.com or fax on +1-800-986-4751 Alternatively, if you like, we can even contact your doctor to obtain a valid prescription.
The maximum amount of Strattera (Atomoxetine) can be ordered at one time is a 90-day supply. The amount that can be ordered is dependent on the instructions and quantity mentioned on your medical prescription. Refilling alternate is always available for future needs.
It is a completely safe and secure choice to order your medicine from us. We function similarly alike any other traditional pharmacy, intending to serve safe and affordable prescription medicines. Our associated pharmacists are functional in many countries and are completely licensed and certified.
Strattera (Atomoxetine) is available in both generic and brand form. Generic medicines contain the same active components as brand-name pharmaceuticals have. They ensure and meet the same quality, strength, and purity standards in comparison to any other brand.
Yes. We deliver all around the United States and other major countries.
LifeRx pharmacy makes it simple to refill your medication. By going to your accounts reorder section, you can easily place a refill option available online. You may examine your prior orders and choose which prescriptions order needs to be refilled. To order a refill, you can also call us and chat with one of our customer service representatives. Our live chat is also one of the convenient ways to reach out to us while placing a refill order.
We do not automatically refill prescriptions as it might be the case where you may no longer be taking the same medicines or your doctor may have revised your dose, among other things. However, we do offer a helpful refill reminder service. Based on your prescription history, we may call or email you to let you know when the ideal time is to place a refill order.
Hiroshngallainen, Bloxx-B, Roussel, Rieck, Rho-K, Bloomspot, Lilliput, Medinor, Olomu, Rosmukald, Sandoval, Vigran, Vej, Vigran Qiao Si Xiaoxu Xiao Qiao Si Qiao Si Qiao Si QiaoStrattera (Atomoxetine) is a prescription medication that contains the active ingredient atomoxetine as its brand name. It is used to treat:
Strattera (Atomoxetine) is usually taken orally with a full glass of water. It may take several weeks for you to understand the effects of this medication.
If you do not understand the detailed instructions for this medication, talk with your doctor.
Medically Reviewed by
Dr. Akansha is a licensed Clinical Pharmacologist with extensive expertise in pharmacovigilance, prescription drug history, drug information, and safety. She's a dedicated educator and avid learner. Akansha also provides valuable insights into the topic of ADHD and seizure disorders, including tips on effective treatment options, risk-benefit analysis, and dosage recommendations. Akansha is passionate about providing exceptional care to millions of patients. She gratefully sleeps through the first day of her medication regimen, ensuring that it can continue for the rest of her life. Akansha is a dedicated educator and avid learner. She also serves as the Executive Director of Medically Reviewed Drugs at WebMD.
Akansha's dedication towards improving patient outcomes and improving healthcare facilities has made her the subject of many healthcare blog posts. She has written numerous reviews on blog posts about her expertise in ADHD medications. She has also authored numerous book chapters on pharmaceuticals and medical devices.
In addition to clinical pharmacology, Dr. Akansha also shares information on patient safety, medication review, and other related topics. Akansha is a licensed Clinical Pharmacologist with extensive knowledge and training in pharmacology, pharmacovigilance, drug information, safety, medication review, and safety assessment. She is a dedicated educator and avid learner.
Read More About ADHD Medication and ADHD Epilepsy [Read More About]Medically Reviewed Drugs (ADHD) [Read More About ADHD Medication and ADHD Epilepsy] [Read Less On Medication Review]Drug Information
ADHD Medication [Read More About ADHD Medication and ADHD Epilepsy] [Read Less On Medication Review] [Read More About Medication Review] [Read Less On Drugs]The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment. You should not start using this drug without consulting your healthcare provider first.
Drug Information [Read More About ADHD Medication and ADHD Epilepsy] [Read Less On Medication Review] [Read More About Medication Review] [Read Less On Drugs]Drug [Read More About ADHD Medication and ADHD Epilepsy] [Read Less On Drugs] [Read More About Medication Review] [Read Less On Drugs]The following drugs may interact with the following drugs: Citalopram [Cipramine], Serotonin-Norepinephrine Reuptake Inhibitor [Prozac, Luvox], Dopamine Dopamine Agonist [Lyrica, Agonist], Methylphenidate [Ritalin], Norepinephrine HCl [Norepinephrine HCl], Phytosterols [Epigram], Stereoisomerase Inhibitors [Strattera, Strattera], Triaminic Acid [Tylenol], Tranylcypromine [Tetrabenamide], Thioridazine [Medrol, Trombobalamine], and Triaminic Acid [Ludiomine].Strattera manufacturer Amneal Atulong said Wednesday it plans to introduce a generic version of its prescription stimulant drug Strattera, the drug's first step toward eliminating the stigma associated with treating ADHD.
Atulong, the world's largest generic drug maker, said its Strattera tablet, which comes in a chewable form, will soon be sold as a generic, making it the first to take the drug's place among the top 10 most prescribed medications in the U. S.
Atulong said Amneal's approval would allow the company to take the drug off the market after a generic version has been launched. Amneal is expected to be sold at half the retail price, with the generics being available in 2023.
Atulong said that at least 30 other companies are working on generic versions of Strattera, including Eli Lilly and Novartis, the maker of Eli Lilly & Co.'s Strattera pill.
Aneal to market
Atulong said Amneal's approval will allow Amneal to market its generic version of Strattera without needing to wait for generics to hit the market, though it is not yet certain how quickly it will start producing generic versions.
Atulong said its generic version will likely be sold at half the retail price, with the generics being available in 2023.
But Amneal's patent on Strattera expires in October, leaving the generic to be sold under a different name, which means it will have to be manufactured under a different name.
Atulong said its Strattera tablet, which comes in a chewable form, will soon be sold as a generic, making it the first to take the drug's place among the top 10 most prescribed medications in the U.
Atulong said Amneal's approval will allow Amneal to take the drug off the market after a generic version has been launched.
The company's generic version of Strattera is expected to be sold at half the retail price, with the generics being available in 2023.
The U. Food and Drug Administration has approved Strattera for treating Attention Deficit Hyperactivity Disorder (ADHD) but the generic version is not yet available yet.
Strattera, which has been in short supply, is also being sold as a generic, Amneal said. It is expected to be sold at half the retail price, with the generics being available in 2023.
The drugmaker's other patents on Strattera include a 2006 patent on the drug and a 2008 patent on the generic version.
Amneal has yet to make a decision on the generics, which could affect its market share for Strattera. Amneal is still seeking approval to sell its generic drug as a generic.
Strattera was launched by Eli Lilly and Company in the U. in 2002 and later changed its name to Strattera in 2003.
Amneal's patent on Strattera expires in October, leaving the generic to be sold under a different name, which means it will have to be manufactured under a different name.
Strattera is the second drug to be approved for treating ADHD in the United States, following the approval of Adderall in 1998.
Atulong said its Strattera was the first to be approved by the FDA since it was approved by the agency in 1986.
The company has said it will manufacture and market the generic version of Strattera, though the drugmaker has yet to discuss its options with the FDA.
Strattera is a prescription medication used in adults with attention-deficit hyperactivity disorder (ADHD).
Strattera tablet, which comes in a chewable form, is to be taken by adult patients with ADHD who are not diagnosed with ADHD, or who have not received a diagnosis or tried their options before.The company will produce Strattera in 2023, though it is not yet certain how soon it will be producing generic versions.
Amneal said that its generics are expected to be available in 2023.
Amneal's approval will allow Amneal to take the drug off the market after a generic version has been launched, though it is not yet certain how quickly it will start producing generic versions.
Amneal's generic version of Strattera will be sold at half the retail price, with the generics being available in 2023.
Stade de France Pharmacy